A kind of medical injection made up of traditional Chinese medicine has been recently permitted by the Russian health authority for clinic application for cancer treatment, sources with Chinese health authority said on Thursday.
The Kanglaite injection contains active substance which is extracted from herb medicine and capable of killing cancer cells and improving people's immunity as well, said sources from the State Administration of Traditional Chinese Medicine.
The remedy was first introduced and produced by the Zhejiang Kanglaite Pharmaceutical Co. Ltd. in 1997. It is widely applied in more than 2,000 Chinese hospitals for over 400,000 cancer patients.
The injection is an achievement of a research group headed by Li Dapeng, a senior expert of Chinese traditional medicine in Zhejiang Province, east China.
It has been granted patent in China, US, EU and Russia.
The injection has been used for clinic experiments for two years in Russia, which proved its well effects on treatment of lung cancer and cancer of stomach, said SATCM sources.
The new medicine was approved by the US FDA (Food and Drug Administration) for clinic experiments in 2001 and the first phase of the experiments has been successfully completed in the Salt Lake City of US.
(Xinhua News Agency July 9, 2004)
